# Kimia Farma Performance Analysis
ğŸŸ¦ Overview

This project aimed to analyze Kimia Farmaâ€™s business performance from 2020 to 2023 across multiple branches, provinces, and product categories. The dashboard delivers interactive insights to assist stakeholders in evaluating sales trends, branch profitability, top products, and customer satisfaction.

ğŸ“˜ Project Background

In large-scale healthcare and pharmaceutical businesses like Kimia Farma, monitoring operational and financial performance across numerous branches, provinces, and product categories poses a significant challenge. With thousands of transactions occurring across clinics, pharmacies, and laboratories nationwide, decision-makers require a centralized view to evaluate business performance efficiently.

This project was initiated to analyze Kimia Farmaâ€™s business performance from 2020 to 2023, consolidating key indicators such as total revenue, transaction volume, net profit, branch ratings, product contribution, and regional profitability into a single interactive Power BI dashboard.

The goal was to generate data-driven insights that would enable management to identify top-performing regions, evaluate product success, monitor year-over-year revenue trends, and optimize strategic planning across branch types and geographies.

ğŸ§© Project Summary

ğŸŸ¥ Problem Statement

The management lacked a visual, consolidated way to monitor province-level performance, top product contribution, and year-over-year revenue trends. This made it difficult to identify declining branches, shifting product demand, and underperforming areas in a timely manner.

ğŸ¯ Objective
1. Monitor total sales, transactions, and net profit across four years (2020â€“2023)
2. Identify top-performing products and regions
3. Analyze revenue trends and customer satisfaction metrics
4. Provide actionable recommendations to improve profitability and operational efficiency

ğŸ›  Tools & Dataset

Tools: Power BI

Dataset: Internal business records from 2020â€“2023 containing:
1. Sales transactions
2. Net revenue
3. Product categories
4. Provincial branch data
5. Ratings (branch vs transaction)
6. Geographical distribution

ğŸ”„ Methodology / Workflow
1. Data Import & Cleaning = Imported structured data into Power BI and ensured quality control for metrics like sales, profit, and region codes.
2. Data Modeling = Connected transactional data with product and location dimensions.
3. Dashboard Design
   Created visual components for:
   - Revenue & profit by year
   - Branch transactions & ratings
   - Product performance
   - Regional profitability via map
   - Comparison of branch types
4. Insight Generation = Identified high-performing categories, peak revenue periods, and branch-level strengths/weaknesses.

ğŸ“ˆ Key Findings / Insights
1. Total Revenue: 347.0B | Net Profit: 98.5B | Transactions: 672.5K
2. Jawa Barat led all provinces in sales and transactions (41.7%)
3. Top products include Psycholeptics (Hypnotics, Anxiolytics), accounting for over 116B in net sales
4. Revenue peaked in 2022, but dropped again in 2023, signaling volatility
5. Kimia Farma â€“ Klinik & Apotek earned the highest branch rating

ğŸ’¡ Recommendations
1. Prioritize inventory, marketing, and expansion in high-performing regions like Jawa Barat
2. Re-evaluate performance in low-profit provinces and identify localized barriers
3. Focus on top-selling product categories (e.g., Psycholeptics) for demand planning and bundling
4. Investigate the revenue drop in 2021 and 2023 to identify operational bottlenecks
5. Improve transaction satisfaction ratings through staff training and service quality improvement

ğŸ’¡ Insights & Recommendations

ğŸŸ¦ Sales & Transaction Performance
1. Insight:
   - Total revenue reached 347.0B with 672.5K transactions and 98.5B in net profit over four years.
   - Most sales and transactions are concentrated in Jawa Barat (41.7%), followed by Sumatera Utara and Jawa Tengah.
2. Recommendation:
   - Continue prioritizing high-performing regions like Jawa Barat, but also assess potential in emerging regions like Riau and Kalimantan Timur for expansion.

ğŸŸ© Top Product Performance
1. Insight:
  - The top-selling product is Psycholeptics drugs, Hypnotics and sedatives, with 134,849 transactions and 59.4B net sales.
  - The second is Anxiolytic drugs (57.2B), indicating high demand for psychotropic product categories.

2. Recommendation:
  - Focus on inventory optimization and marketing for these top products.
  - Consider developing supporting products in the same therapeutic category to enhance cross-selling.

ğŸŸ¨ Regional Profitability
1. Insight:
   - Profit distribution shows clear dominance in Java-based provinces, with lower profit contributions from provinces in Eastern Indonesia.

2. Recommendation:
   - Conduct market penetration assessments in underperforming provinces and tailor regional strategies to boost profitability.

ğŸŸ¥ Year-over-Year Revenue Trend
1. Insight:
   - Revenue peaked in 2022, but overall trend is slightly declining, especially in 2021 and 2023.

2. Recommendation:
   - Investigate operational, economic, or policy changes that may have affected revenue, and consider launching nationwide or regional sales programs to stabilize growth.

ğŸŸª Branch Rating vs Transaction Rating
1. Insight:
   - Kimia Farma â€“ Klinik & Apotek received the highest branch rating, while transaction rating is relatively flat across all types.

2. Recommendation:
   - Explore customer experience improvements and staff training to increase transaction satisfaction, especially for branches with lower ratings but high traffic.

ğŸ† Business Impact / Outcome
1. Provided a centralized, executive-level dashboard that empowers leadership with real-time business visibility
2. Enabled the company to make data-driven decisions on sales strategy, product focus, and regional operations
3. Supported strategic planning by identifying growth potential and performance gaps across branches

ğŸ“ Lessons Learned
1. Consistent data structure is key for long-term performance tracking
2. Geographical visualization is powerful for multi-branch organizations
3. Business insights are most effective when paired with clear, actionable recommendations
4. Even complex healthcare and retail data can be simplified into a user-friendly dashboard for non-technical stakeholders

ğŸ“« Contact

Created by Atika Rahmah

For inquiries: atikachanita@outlook.co.id

LinkedIn: linkedin.com/in/atika-rahmah/
